Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 0591-0860

5 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 0591-0860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
Chemical structure diagram of lisinopril, showing its molecular components and arrangement, including a phenyl group, amino acids, and a cyclic structure, with two water molecules indicated as hydrates.*
FDA Label Image

Image 2

Image 2
Chemical structure diagram of the active ingredient in the product, showing a sulfonamide-substituted benzene ring connected to a heterocyclic ring with nitrogen and sulfone groups, representing the molecular structure related to lisinopril and hydrochlorothiazide combination tablets by Actavis Pharma, Inc.*
FDA Label Image

Image 3

Image 3
Label for Lisinopril and Hydrochlorothiazide Tablets, USP 10 mg/12.5 mg by Actavis Pharma, Inc., featuring 100 tablets in the package. The label states the strengths of each tablet and provides manufacturer and distributor information, storage instructions, and a barcode with the NDC 0591-0860-01.*
FDA Label Image

Image 4

Image 4
Label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg, manufactured by Watson Pharma Private Limited and distributed by Actavis Pharma, Inc. The label indicates a package containing 100 tablets, with storage and dispensing information, barcode, and serialization coding area.*
FDA Label Image

Image 5

Image 5
Label for Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/25 mg strength. The label indicates packaging of 100 tablets, marked Rx Only, distributed by Actavis Pharma, Inc. It lists active ingredients with dosages and instructs on storage and protection from light and humidity. Manufactured by Watson Pharma Private Limited, India. Includes barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.